000 01438 a2200397 4500
005 20250511175743.0
264 0 _c19931018
008 199310s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1992.tb51641.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSeifried, E
245 0 0 _aBolus application of a novel recombinant plasminogen activator in acute myocardial infarction patients: pharmacokinetics and effects on the hemostatic system.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cDec 1992
300 _a417-20 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHalf-Life
650 0 4 _aHemostatics
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyocardial Infarction
_xblood
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aTissue Plasminogen Activator
_xadministration & dosage
700 1 _aMüller, M M
700 1 _aMartin, U
700 1 _aKönig, R
700 1 _aHombach, V
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 667
_gp. 417-20
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1992.tb51641.x
_zAvailable from publisher's website
999 _c1315585
_d1315585